Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

CYP3A4/5 combined genotype analysis for predicting statin dose requirement for optimal lipid control.

Kitzmiller JP, Sullivan DM, Phelps MA, Wang D, Sadee W.

Drug Metabol Drug Interact. 2013;28(1):59-63. doi: 10.1515/dmdi-2012-0031.

PMID:
23314529
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.

Prueksaritanont T, Ma B, Tang C, Meng Y, Assang C, Lu P, Reider PJ, Lin JH, Baillie TA.

Br J Clin Pharmacol. 1999 Mar;47(3):291-8.

PMID:
10215754
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy.

Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH.

Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):75-81. doi: 10.1002/pds.1866.

PMID:
19802823
[PubMed - indexed for MEDLINE]
4.

Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.

Saw J, Brennan DM, Steinhubl SR, Bhatt DL, Mak KH, Fox K, Topol EJ; CHARISMA Investigators.

J Am Coll Cardiol. 2007 Jul 24;50(4):291-5. Epub 2007 Jul 10.

PMID:
17659194
[PubMed - indexed for MEDLINE]
Free Article
5.

Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study.

Tirkkonen T, Ryynänen A, Vahlberg T, Irjala K, Klaukka T, Huupponen R, Laine K.

Drug Saf. 2008;31(3):231-40.

PMID:
18302447
[PubMed - indexed for MEDLINE]
6.

Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.

Molden E, Skovlund E, Braathen P.

Drug Saf. 2008;31(7):587-96.

PMID:
18558792
[PubMed - indexed for MEDLINE]
7.

Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.

Trenk D, Hochholzer W, Frundi D, Stratz C, Valina CM, Bestehorn HP, Büttner HJ, Neumann FJ.

Thromb Haemost. 2008 Jan;99(1):174-81. doi: 10.1160/TH07-08-0503.

PMID:
18217151
[PubMed - indexed for MEDLINE]
8.

The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.

Vinholt P, Poulsen TS, Korsholm L, Kristensen SR, Hallas J, Damkier P, Mickley H.

Thromb Haemost. 2005 Aug;94(2):438-43.

PMID:
16113837
[PubMed - indexed for MEDLINE]
9.

Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study.

Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS.

Curr Med Res Opin. 2008 Jul;24(7):1987-2000. doi: 10.1185/03007990802203279 . Epub 2008 Jun 4. Erratum in: Curr Med Res Opin. 2010 Mar;26(3):631.

PMID:
18554430
[PubMed - indexed for MEDLINE]
10.

Platelet aggregation inhibition in patients receiving statins either fully or partially metabolized by CYP3A4.

Polena S, Gupta MP, Shaikh H, Zazzali K, Coplan N, Gintautas J, Labana SS, Soffer D.

Proc West Pharmacol Soc. 2008;51:60-2.

PMID:
19544679
[PubMed - indexed for MEDLINE]
11.

Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.

Hoch M, Hoever P, Theodor R, Dingemanse J.

Eur J Clin Pharmacol. 2013 Jun;69(6):1235-45. doi: 10.1007/s00228-012-1470-8. Epub 2013 Jan 20.

PMID:
23334403
[PubMed - indexed for MEDLINE]
12.

Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population.

Bakhai A, Rigney U, Hollis S, Emmas C.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):485-93. doi: 10.1002/pds.2308. Epub 2012 Jan 12.

PMID:
22237927
[PubMed - indexed for MEDLINE]
13.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
[PubMed - indexed for MEDLINE]
14.

Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy.

Devold HM, Molden E, Skurtveit S, Furu K.

Br J Clin Pharmacol. 2009 Feb;67(2):234-41. doi: 10.1111/j.1365-2125.2008.03345.x. Epub 2009 Feb 9.

PMID:
19220274
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Phenotyping of cytochrome P450 3A enzyme in Gujarat population.

Jani AJ, Rathnam S, Mehta AA.

Drug Metab Lett. 2008 Jan;2(1):5-10.

PMID:
19356063
[PubMed - indexed for MEDLINE]
16.

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.

Saw J, Steinhubl SR, Berger PB, Kereiakes DJ, Serebruany VL, Brennan D, Topol EJ; Clopidogrel for the Reduction of Events During Observation Investigators.

Circulation. 2003 Aug 26;108(8):921-4. Epub 2003 Aug 18.

PMID:
12925453
[PubMed - indexed for MEDLINE]
Free Article
17.

Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.

Geleedst-De Vooght M, Maitland-van der Zee AH, Schalekamp T, Mantel-Teeuwisse A, Jansen P.

Drugs Aging. 2010 Jul 1;27(7):589-96. doi: 10.2165/11537330-000000000-00000.

PMID:
20583852
[PubMed - indexed for MEDLINE]
18.

Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.

Park Y, Jeong YH, Tantry US, Ahn JH, Kwon TJ, Park JR, Hwang SJ, Gho EH, Bliden KP, Kwak CH, Hwang JY, Kim S, Gurbel PA.

Eur Heart J. 2012 Sep;33(17):2151-62. doi: 10.1093/eurheartj/ehs083. Epub 2012 Apr 16.

PMID:
22507978
[PubMed - indexed for MEDLINE]
Free Article
19.

Dose-related effect of statins on atrial fibrillation after cardiac surgery.

Kourliouros A, De Souza A, Roberts N, Marciniak A, Tsiouris A, Valencia O, Camm J, Jahangiri M.

Ann Thorac Surg. 2008 May;85(5):1515-20. doi: 10.1016/j.athoracsur.2008.01.040.

PMID:
18442529
[PubMed - indexed for MEDLINE]
20.

Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.

Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JL, Seman LJ, Ferrari A, Rubenstein JJ.

Am J Cardiol. 2004 Jan 1;93(1):31-9.

PMID:
14697462
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk